Admission Date:  [**2118-2-15**]              Discharge Date:   [**2118-2-24**]  Date of Birth:  [**2044-4-29**]             Sex:   F  Service: MEDICINE  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**First Name3 (LF) 1185**] Chief Complaint: Pneumonia  Major Surgical or Invasive Procedure: None   History of Present Illness: Ms. [**Known lastname **] is a 73yoF with a h/o CLL on rituximab, L breast ca Stage I s/p lumpectomy and radiation who presents with cough and SOB.
She received 1g tylenol, 1g IV ceftriaxone x1 and 500mg azithromycin PO x1.
She was admitted to medicine for further management.
Denies recent HA, rhinorrhea, sore throat, chest pain, nausea/vomiting, abdominal pain.
Past Medical History: CLL - Recent e/o progression with lymphadenopathy, started rituxan therapy on [**2118-1-25**] Left breast infiltrating ductal carcinoma, stage I, 0.4 cm, ER/PR positive, HER-2/neu negative, with associated DCIS - s/p lumpectomy and radiation [**2113**], did not tolerate hormonal therapy (anxiety/depression) HTN Anxiety   Social History: CLL - Recent e/o progression with lymphadenopathy, started rituxan therapy on [**2118-1-25**] Left breast infiltrating ductal carcinoma, stage I, 0.4 cm, ER/PR positive, HER-2/neu negative, with associated DCIS - s/p lumpectomy and radiation [**2113**], did not tolerate hormonal therapy (anxiety/depression) HTN Anxiety   Family History: Paternal aunt with a history of breast cancer at older age, sister just recently died of metastatic renal cell carcinoma to the brain.
Pertinent Results: Admission Labs: [**2118-2-15**] 02:30PM BLOOD WBC-3.7* RBC-4.13* Hgb-12.6 Hct-39.9 MCV-97 MCH-30.6 MCHC-31.6 RDW-13.7 Plt Ct-348 [**2118-2-15**] 02:30PM BLOOD Neuts-78.4* Lymphs-21.0 Monos-0.1* Eos-0.1 Baso-0.3 [**2118-2-15**] 02:30PM BLOOD Glucose-150* UreaN-19 Creat-0.7 Na-135 K-4.0 Cl-99 HCO3-22 AnGap-18 [**2118-2-16**] 03:26AM BLOOD Calcium-7.6* Phos-3.5 Mg-2.3  Blood Gas prior to MICU Transfer: [**2118-2-15**] 10:28PM BLOOD Type-ART pO2-61* pCO2-24* pH-7.54* calTCO2-21 Base XS-0  Discharge Labs: [**2118-2-24**] 06:10AM BLOOD WBC-6.1 RBC-4.08* Hgb-12.2 Hct-38.6 MCV-95 MCH-29.9 MCHC-31.6 RDW-14.3 Plt Ct-535* [**2118-2-24**] 06:10AM BLOOD Glucose-107* UreaN-24* Creat-0.6 Na-132* K-4.8 Cl-101 HCO3-24 AnGap-12 [**2118-2-24**] 06:10AM BLOOD Calcium-8.2* Phos-3.8 Mg-2.1  Micro:  [**2118-2-16**] 01:25AM BLOOD B-GLUCAN- Results                                 Reference Ranges -------                                 ---------------- 327 pg/mL                               Negative       Less than 60 pg/mL                                         Indeterminate  60 - 79 pg/mL                                         Positive       Greater than or equal to                                                        80 pg/mL  [**2118-2-18**] 6:06 am STOOL     CONSISTENCY: WATERY      Source: Stool.
Furthermore, in       infected patients the excretion of antigen in urine may vary.
Severe multifocal pneumonia, which can be monitore on conventional chest radiographs.
Brief Hospital Course: Primary Reason for Hospitalization: Ms. [**Known lastname **] is a 73yoF with a h/o CLL treated with one dose of rituximab 3 weeks ago, admitted for pneumonia with course c/b hypoxia requiring transfer to ICU.
Active Issues:  # Community-acquired pneumonia/Hypoxia: Pt presented with fever, hypoxia, and bilateral pulmonary infiltrates c/w pneumonia.
She was placed on 50% FIO2 facemask and continued to be tachypeneic, with ABG pH 7.54 pCO2 24 pO2 61 HCO3 21.
Her antibiotics were broadened to vanc/zosyn/azithro on [**2118-2-15**], and on [**2-17**] she was started on IV Bactrim 300mg Q8H and IV Methylpred 20mg Q8H due to clinical concern for PCP given her immunocompromised state and rapid clinical deterioration.
She was never bronched due to concern of weaning off the ventilator after elective intubation.
After 6 days of vanc/zosyn/azithromycin, antibiotics were narrowed and she was switched from IV to PO Bactrim for empiric treatment of PCP.
Her O2 requirement gradually decreased and on day of discharge she was maintaining O2 sats >92% on RA with ambulation.
She was continued on PO steroid taper (40mg [**Hospital1 **] x5 days, 40mg daily x5 days, 20mg daily x11 days).
# HTN: Stable on home diltiazem.
# L breast ca: Stage I ER/PR+ Her2-, s/p lumpectomy and radiation.
Not currently on hormonal therapy (did not tolerate).
Transitional Issues: -Medication changes: STARTED PO Bactrim DS 2 tablets TID, should complete 14 day course and then transition to prophylactic dosing of 1 SS tablet daily; STARTED PO prednisone taper (40mg [**Hospital1 **] x5 days, 40mg daily x5 days, 20mg daily x11 days).
Diltzac ER 180 mg Capsule, Extended Release Sig: One (1) Capsule, Extended Release PO once a day.
2. prednisone 20 mg Tablet Sig: Two (2) Tablet PO once a day for 4 days: Take two tablets daily until [**2-28**], then decrease to 1 tablet daily until [**3-11**].
Disp:*19 Tablet(s)* Refills:*0* 3. sulfamethoxazole-trimethoprim 800-160 mg Tablet Sig: Two (2) Tablet PO TID (3 times a day) for 7 days: Take until [**3-2**].
Bactrim 400-80 mg Tablet Sig: One (1) Tablet PO once a day: Start after you complete your course of DS Bactrim (start [**3-3**]).
You were treated with antibiotics and steroids and your breathing improved.
Please note the following changes to your medications: -START Bactrim DS 2 tablets three times daily for 7 days including today -START Prenisone 40mg daily for 5 days including today, then decrease dose to 20mg daily for 11 days -After you finish Bactrim DS, start Bactrim SS 1 tablet daily  We made no other changes to your medications while you were in the hospital.
Please continue taking the rest of your medications as prescribed by your outpatient providers.
